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Abstract 32 
Background:  Vaccination is considered the most effective preventive measure against influenza 33 
transmission, yet vaccination rates during the 2009/10 influenza A/H1N1 pandemic were low across 34 
the world, with the majority of people declining to receive the vaccine.  Despite extensive research on 35 
the predictors of uptake of influenza vaccination, little research has focused on testing the 36 
effectiveness of evidence and theory-based messages. 37 
Aims:  To examine the persuasiveness of messages promoting vaccination and antiviral use either as 38 
health-enhancing or as risk-reducing, as well as messages which conveyed evidence-based 39 
information about the costs and benefits of vaccination, or which applied anticipated regret as a 40 
motivator for vaccine uptake. 41 
Method:  We conducted 11 focus groups with forty-one members of the general population in England 42 
including young and older adults, those with lower education, parents, and those with elevated health 43 
risk.  The data were analysed using thematic analysis. 44 
Results:  The factual, evidence-based messages were well received with participants finding them the 45 
most convincing and useful, particularly where they gave cost-benefit comparisons. Health-enhancing 46 
messages were received with scepticism and concern that the messages were not honest about the 47 
potential lack of safety of vaccination. In contrast, risk-reduction messages were perceived as being 48 
more balanced and credible. Messages aiming to elicit feelings of anticipated regret for not getting 49 
vaccinated were generally perceived as patronising and unprofessional.   50 
Conclusions:  Vaccination messages should be kept brief, but convey balanced, evidence-based 51 
information, and be transparent in their communication of potential side-effects. The general public 52 
seem to prefer messages that are factual and emphasise the costs and benefits of vaccination, 53 
particularly with regards to vaccine safety.   54 
Keywords: influenza; pandemic; risk communication; vaccination 55 
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1. Introduction 56 
Influenza pandemics arise when little or no immunity to a new virus exists, leading to transmission 57 
and spread of disease (WHO, 2013) and creating levels of uncertainty and unpredictability that have 58 
the potential to severely impact populations worldwide (1, 2). Public health experts consider 59 
vaccination to be the most effective mechanism for minimising the impact of an influenza pandemic 60 
(3), but this relies on public engagement. In the United Kingdom,  many people declined vaccination 61 
during the 2009/10 influenza A/H1N1 pandemic, even among specifically targeted patient groups (4) 62 
and healthcare workers (5, 6) with uptake ranging from 20.8% (the lowest), in those aged 16-25 years, 63 
to 48.2% (the highest), in those aged 60-65 years in a clinical risk group (4). 64 
Research investigating psychological predictors of vaccination uptake found that uptake is associated 65 
with a history of previous vaccination for seasonal influenza (5, 7), perceiving the disease as more 66 
severe (8, 9) and the vaccine as effective and safe (5, 7). Factors reducing vaccination intentions 67 
include scepticism about the level of threat, not perceiving oneself to be at risk, especially if one is 68 
currently healthy, and concerns about vaccination safety and potential negative side-effects (10-14). 69 
Research suggests that these barriers might be addressed by emphasizing the positive benefits of 70 
vaccination (15, 16), while also allaying public concerns about vaccination safety and side-effects. To 71 
increase vaccination uptake during future pandemics, one way to communicate effectively with the 72 
public is to draw on relevant theories of risk communication pertaining to behaviour change. Given 73 
that the lay public relies on social trust to make decisions about risks and benefits particularly when 74 
they lack personal knowledge about a hazard (17), messages advocating vaccination could be made 75 
more transparent and thus trustworthy, e.g. by acknowledging uncertainty around the benefits of 76 
vaccination. Also, given that any situation involving risk can be ‘framed’ in two different but logically 77 
equivalent ways, e.g. lives saved vs. lives lost, attention should be paid to how the risk of pandemic 78 
influenza is communicated. Message framing can impact persuasiveness and thus risk perception, as 79 
highlighted by Prospect Theory (18), with gain-framed messages being more effective than loss-80 
framed messages at encouraging prevention behaviours (19, 20). 81 
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One way to frame precautionary messages is to highlight the reduction of risk vs. the enhancement of 82 
benefits. The main aim of this study was to compare the persuasiveness of messages promoting 83 
vaccination as entailing health benefits (health-enhancing) versus those communicating vaccination 84 
as reducing risk of infection (risk-reducing). Messages conveying health enhancement were expected 85 
to be viewed more positively than messages presenting vaccination as a means of risk reduction (14). 86 
Additionally, we tested messages presenting evidence that the risk of harm from pandemic influenza 87 
is greater than the risk of vaccination side-effects by prompting people to imagine how they might 88 
feel if they refused vaccination and then became ill (anticipated regret), and presenting factual 89 
messages about the relative costs and benefits of vaccination of the A/H1N1 pandemic (transparency). 90 
It was expected that evoking anticipated regret may strengthen the message impact, in light of 91 
research showing that vaccination intentions tend to be stronger when failing to act is associated with 92 
negative emotions that people wish to avoid (27). 93 
Additionally, we examined reactions to messages about antiviral medicines, as besides treatment, 94 
these can play a prophylactic role against pandemic influenza, yet little is known about public attitudes 95 
towards their use. During the A/H1N1 pandemic in 2009/10, Australian research participants were 96 
willing to take a full course of antiviral drugs if exposed to a person with pandemic influenza (21), 97 
while US pregnant and recently pregnant women participating in focus groups indicated being poorly 98 
informed about antivirals and concerned about using them in pregnancy (22). Recent research with 99 
the UK public has indicated that lay people knew little about influenza antivirals, confusing them with 100 
antibiotics, yet viewed antivirals advice as sensible and acceptable (14). 101 
2. Methods 102 
2.1 Design 103 
Eleven focus groups (40-60 minutes) were conducted with 41 members of the UK general public 104 
between October 2014 and July 2015. We used maximum variation sampling to include participants 105 
from populations varying in their likelihood to suffer complications as a result of influenza infection, 106 
e.g. parents of babies, younger and older adults, to examine a variety of views on vaccination. As we 107 
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were particularly interested in assessing the impact of messages on increasing vaccination intentions 108 
amongst non-vaccinators, we recruited wherever possible participants who were not annual influenza 109 
vaccinators (80.5% of our sample). Given the large number of messages to be tested individually 110 
(n=23), we used small-sized focus groups to be able to gauge in-depth the participants’ reasoning 111 
around the messages.  112 
Recruitment was by email and paper adverts through the University of Southampton and community 113 
groups. Each participant received an information sheet explaining the study and that participation was 114 
both confidential and voluntary, and £10 for participating in the research. Written consent was 115 
obtained before any data collection and ethical approval was granted by the University of 116 
Southampton Ethics Committee. 117 
2.2 Procedure 118 
Participants were presented with a brief, hypothetical scenario describing what might happen during 119 
a pandemic influenza outbreak (Figure 1), including information on health consequences, impact and 120 
vaccination advice. This was based on existing work (14, 15), which involved extensive consultation 121 
with public health and primary care practitioners. Open questions elicited participants’ initial reactions 122 
before a series of messages, each containing four statements, were shown (Table 1). Messages were 123 
designed for dissemination through Twitter and social media networks, as during the A/H1N1 124 
influenza pandemic the public obtained information from social media as well as from official health 125 
sources (23). Two message sets covered vaccination, and two, antiviral medications, with messages 126 
framed both negatively (focus on risk-reduction) and positively (focus on health-enhancement), with 127 
order of message presentation altered for each focus group. Participants were shown two further 128 
message sets: one set of three emotion-focused messaged elicited anticipated regret and one set of 129 
four factual messages provided cost-benefit information about the A/H1N1 vaccination. Positively- 130 
and negatively-framed messages were based on previous research showing that participants denied 131 
being at risk of infection, arguing that they were ‘fit and healthy’, with a strong immune system or 132 
‘healthy lifestyle’ (14, 15). The emotion-focused messages were developed based on the omission bias 133 
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and anticipated regret literature: omission bias refers to perceiving the potential harm from action 134 
(e.g. vaccination) as more negative than the potential harm from inaction (e.g. not getting vaccinated) 135 
(24, 25); anticipated regret refers to the level of regret one expects to feel when choosing (or not) a 136 
particular course of action (26). The fact-based messages were designed to test whether transparent, 137 
evidence-based information could increase trust and vaccination intentions as suggested by earlier 138 
work (5). After each set of messages, the moderator (first or second author) asked a series of open 139 
questions about participants’ thoughts, reactions, and feelings, about the messages. Demographic 140 
data were collected after each group. 141 
2.3 Data analysis 142 
Focus groups were digitally audio-recorded and transcribed verbatim. Inductive thematic analysis of 143 
each transcript was carried out (27), supported by use of QSR NVivo 10.0 software, and coded into 144 
emerging themes, which represented prevalent patterns of meaning within the dataset  without these 145 
necessarily being highly frequent (28). Analysis was iterative, with two researchers independently 146 
reading and re-reading each transcript. Following consultation, the initial coding structure was revised 147 
to develop a consensus on the codes and themes. Coding followed the aims of the research, focusing 148 
on participants’ reactions to each message set.   149 
3. Results 150 
Thirty-two (78%) women and nine (22%) men participated, with an age range of 19-77 and a median 151 
age of 33 (SD=15.9). Of the participants, 19.5% had regularly received the seasonal influenza 152 
vaccination since the A/H1N1 pandemic. Full demographic details are available in Table 2. Results for 153 
vaccination and antiviral messages were combined due to similarity in participant responses; we 154 
highlight differences where present. 155 
3.1 Positively framed, health-enhancing messages 156 
Participants within each group had concerns that the health-enhancing messages (messages 1b-8b) 157 
down-played the severity of the situation, or expressed scepticism surrounding the validity of health-158 
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enhancing claims and the seemingly counter-intuitive message that a vaccine could boost the immune 159 
system. Such claims were seen as unfounded given the novelty of the vaccine. For most, scepticism 160 
stemmed from a belief that the messages were misleading, implying that only vaccination or antiviral 161 
treatment could improve health. Several participants mentioned other measures may also improve 162 
health and that further information was needed about how treatments worked: 163 
‘It’ll prevent you from getting flu, but it’s not going to prevent you from getting other infections, 164 
so it’s kind of misleading.’ (FG5, female, 20) 165 
Some participants expressed concerns that the messages seemed too “casual” or “relaxed” for a 166 
pandemic emergency, while others felt that the language and style of the messages seemed more 167 
appropriate for vitamin pills rather than vaccination or antiviral medication. For some, the messages 168 
came across as “pushy” or “intimidating”. Several participants reported feeling that the messages 169 
were implying that their own natural defences or current health state were inadequate:  170 
‘It tells you that maybe your natural defences aren’t good enough. I think mine are fine.’ (FG3, 171 
male, 65)   172 
However, there were some who viewed the messages more positively, feeling that the statements 173 
would not cause alarm or overburden people with medical terminology. They liked how the language 174 
of the messages allowed for personal choice as the tone felt more advisory than threatening. Overall, 175 
participants felt that the messages could be improved through the inclusion of more evidence about 176 
effectiveness and the way treatments work.   177 
3.2 Negatively framed, risk-reducing messages 178 
Participants had mixed reactions to the risk-reducing messages (messages 1a-8a), i.e., some 179 
participants held ambivalent views on the four risk-reduction messages, liking some more than 180 
others. . However, feedback on the risk-reduction messages tended to be positive, particularly when 181 
compared with the health-enhancing ones. Messages were found to be clear and convincing, and 182 
written in sensible language that did not feel patronizing or threatening. Language such as ‘reduces 183 
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risk’ increased the perceived accuracy and trustworthiness of the message by allowing room for the 184 
admission that vaccination or antiviral medications may not be 100% effective for all people, thus 185 
appearing more open and honest:  186 
‘The ones that say ‘reduce the risk’ are more convincing than the ones that say ‘prevent’. 187 
Everybody’s heard of having the flu jab and still getting ill afterwards, so it’s more convincing.’ 188 
(FG2, female, 30) 189 
Focusing on risk reduction provided participants with more information about the consequences of 190 
refusing vaccination, which they felt would help them to make a decision regarding treatment uptake.  191 
For others, the message that being vaccinated or taking antivirals would prevent the spread of illness 192 
to their family or colleagues was the most persuasive:  193 
‘…my concern is spreading it to my parents at some point because they’re less likely to be able 194 
to fight it off successfully without complications.’ (FG1, female, 30) 195 
Negative evaluations of the risk-reducing messages were less common, but were discussed by all 196 
groups and were more evident in relation to the antiviral messages than the vaccination messages.  197 
Several of the antiviral messages were aimed at those in a 'priority group’, e.g. people with an 198 
underlying health condition (messages 5a & 8a), which some participants reported finding worrying 199 
as they did not know if this related to them, or because it sounded like special treatment being 200 
reserved for some groups.  201 
3.3 Emotion-focused, anticipated regret messages 202 
The message comparing the risk of experiencing vaccination side-effects to the risk of harm from 203 
pandemic influenza (message 11) was the most popular as participants liked the way the message 204 
showed two sides to the issue: acknowledging that vaccination side-effects are possible, yet weighing 205 
these against the risk of contracting influenza:  206 
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‘That statement does say the risk of side-effects, but it says the risk of harm from flu is higher 207 
than the risk of side-effects, which sort of minimises the possibility.’ (FG3, female, 67) 208 
Although participants preferred the risk comparison message over others, many reported that they 209 
only liked this section of the statement and would change or remove the section that explicitly 210 
mentioned regret. Across all groups, participants largely  disliked the use of the terms ‘regret’ and 211 
‘upset’ within messages which they considered “unprofessional” and “less authoritative”, and not 212 
necessarily reflecting how they would respond emotionally:  213 
‘I think [the statement] is a bit patronizing, I don’t want to be told when I’m likely to feel upset 214 
about something.’ (FG7, female, 35) 215 
The majority of participants also disliked the message which mentioned a small risk of unknown, long-216 
term effects from vaccination (message 9), as this would provoke fear or alarm, reduce levels of trust, 217 
and draw attention away from the positive aspects of vaccination. Participants generally reported that 218 
they would like more detailed information about potential side-effects, although a couple mentioned 219 
finding this unnecessary as it could make vaccination sound “too risky”. In addition, participants 220 
mentioned that the most trusted and credible information source during a pandemic would be health 221 
authorities such as the UK’s Department of Health, and that they would not expect to receive these 222 
emotion-focused messages from professional sources. 223 
3.4 Fact-focused messages 224 
Balanced messages presenting the risks and benefits of the past A/H1N1 pandemic were generally 225 
well received due to their inclusion of factual information (messages 12-15), as the facts and numbers 226 
made the messages more striking and convincing, particularly as it appeared that they were providing 227 
“evidence” and not just unsubstantiated “advice”. Several participants spoke about preferring these 228 
messages to others as the amount of information included enabled them to make their own decision 229 
about vaccination or treatment:  230 
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‘They don’t feel manipulative. It feels just like you’re being sent information for you to be able 231 
to make your own decision.’ (FG7, male, 36) 232 
The statistical information gave participants a reference point from which to make more meaningful 233 
judgements about the risk and severity of both the pandemic threat and the vaccination. In addition, 234 
several participants felt that the messages were made more compelling by focusing on the impact of 235 
the A/H1N1 pandemic on children, as they could have the potential to invoke stronger emotions in 236 
others (e.g. fear), particularly those with children, although they did not necessarily elicit stronger 237 
emotions. There were no gender-specific responses to these fact-based child-focused messages 238 
among the participants.   239 
Some participants found the factual messages less accessible, saying the statistics might confuse 240 
people and mentioning side-effects such as narcolepsy could cause concern as not everyone would 241 
understand such terms.  It was considered preferable to avoid mentioning serious side-effects as these 242 
may discourage some people from getting vaccinated. There was also some scepticism about the 243 
messages, particularly the claim that vaccination would have saved the lives of children who died 244 
during the A/H1N1 pandemic (message 14).   245 
4. Discussion 246 
This study offers novel insights into how the general public may be likely to respond to messages 247 
advocating vaccination and antiviral medicines. Participants largely preferred the risk-reducing 248 
messages, perceiving them as more balanced and credible, particularly when compared to health-249 
enhancing messages, which elicited greater scepticism. Factual, evidence-based messages 250 
emphasising the costs and benefits of vaccination were well received, while emotion-focused 251 
messages explicitly aiming to evoke feelings of anticipated regret were generally seen as patronising 252 
or unprofessional.  253 
Previous research indicates that those who view themselves as healthy are less likely to accept 254 
influenza vaccination (14, 16, 29, 30). Despite our aim to reinforce healthy identities by framing 255 
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vaccination as a way to maintain or improve health in the health-enhancing messages, we found that 256 
these were unexpectedly perceived as challenging participants’ existing perceptions of themselves as 257 
healthy. The present vaccination messages served as the basis of a companion study employing an 258 
online experimental design which found that the health-enhancing messages were as effective in 259 
promoting vaccination intentions as those framed as risk-reducing (31). Perhaps this difference can be 260 
explained by focus group participants spending greater time critically reflecting on each message in 261 
order to engage in discussion, compared with the online experiment where participants may have 262 
engaged with the messages in a more cursory and/or passive manner. This corroborates research 263 
showing that when more time is spent carefully evaluating messages, negatively phrased information 264 
is perceived as more convincing than equivalent positively phrased information (32).   265 
Participants often reported perceiving the risk-reduction messages as more credible and balanced, 266 
suggesting that presenting health messages positively may not be advisable when uncertainty exists 267 
around the effectiveness of recommended behaviours (33). Some participants viewed the mention of 268 
risk in the risk-reduction messages as acknowledging that vaccination could not guarantee good health, 269 
whereas the health-enhancing messages appeared ‘one-sided’ due to focusing only on how 270 
vaccination can improve health. This links to earlier research showing that two-sided messages are 271 
viewed more credibly (34), and highlights the importance of directly addressing vaccination concerns 272 
(15). 273 
Participants largely perceived the messages aiming to evoke feelings of anticipated regret as 274 
patronising.  Previous studies examining the impact of anticipated regret on various health behaviours 275 
have produced inconsistent results, such as studies investigating the role of anticipated regret in 276 
vaccination intentions (26).  A review of the literature on inducing regret (35) suggests that strong pre-277 
intervention intentions to engage in a behaviour (36) and a lack of defensive resistance (37) may 278 
predict the success of anticipated regret as a driver of behaviour change. Therefore, the rejection of 279 
our messages may be explained by our purposive sampling of people who had not previously been 280 
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vaccinated, and who were thus likely to have weak vaccination intentions. It may also be possible to 281 
induce regret less explicitly, which may be viewed more positively by the public.  282 
4.1 Recommendations 283 
The present findings, albeit based on a small sample of participants, suggest that transparent and 284 
balanced messages have the potential to encourage the general public to vaccinate during a pandemic 285 
influenza outbreak, and we propose several ways to do so. First, messages could incorporate more 286 
evidence-based information, particularly in relation to the safety of vaccines or antiviral medicines. 287 
Messages that present vaccination costs and benefits, or compare risks posed by vaccination to those 288 
posed by contracting pandemic influenza, allow people greater opportunity to feel that they have 289 
control over their own health. Indeed, previous research has demonstrated that appraising one’s 290 
ability to cope with a given health threat, including cost-benefit perceptions, are an important 291 
predictor of intentions and behaviour (38, 39). Uncertainty surrounding pandemic emergence and 292 
vaccine development can affect the public’s willingness to vaccinate (40), so it is imperative that 293 
communicators provide certainty wherever possible, while also being transparent about where 294 
uncertainty exists and why. Our present findings on the positive reactions to the transparent, fact-295 
based messages warrant further research on how to improve trust in risk communicators as a 296 
precursor of vaccination acceptance.  Given that the public prefer health advice from official health 297 
authorities (41), communicators should think about how to build trust by challenging existing 298 
misconceptions about pandemic influenza and vaccination, as well as the governance of their risks. 299 
Finally, this study illustrates that public health messages may not always be received as intended (42), 300 
suggesting that further work into the impact of emotion-focused messaging could be beneficial.  301 
4.2 Limitations 302 
This study employed a relatively small sample and as such cannot be held to represent the views of 303 
the general public. Nor could we draw any conclusions to reflect the views of any specific sub-group, 304 
e.g. mothers of young babies. Yet, we believe our study has ‘information power’ (43), as the study aim 305 
was narrow, the study design was informed by theory, the participant sample was dense, and the 306 
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quality of the dialogue was strong. We would have preferred to include a greater number of men, 307 
older adults and patients with chronic health conditions, but  in line with previous findings (44, 45),  308 
many  who expressed interest to participate were ineligible. Further research with these populations 309 
is needed to ensure generalisability of the present results. Opportunity sampling was used due to time 310 
and monetary constraints, but future research should sample a wider swathe of the UK public to 311 
increase representativeness. Furthermore, we used a scenario to elicit behavioural intentions. 312 
Although behaviour can only be directly measured during a pandemic, it is important to note that 313 
intentions are not always a completely accurate indicator of behaviour (46). For example, the 314 
emotional impact of messages may have direct effects on behaviour that are not accessible to 315 
participants’ awareness.  316 
4.3 Conclusions 317 
Pandemic influenza communication should convey transparent, evidence-based information. The 318 
general public appear to prefer factual messages that emphasise the costs and benefits of vaccination, 319 
particularly with regards to vaccine safety. It would also be advantageous to challenge existing 320 
misperceptions and address topics of uncertainty where possible. Although it is not feasible to pre-321 
test messages for all potential pandemic situations and populations, it remains important to test the 322 
key components of messaging as this is the best way to ensure maximum effectiveness and reduce 323 
the chances of unintentional, negative impacts.  324 
 325 
Acknowledgements  326 
This research was conducted as part of the project Improving Communication With the Public About 327 
Antivirals and Vaccination During the Next Pandemic, funded by the Department of Health through 328 
the Policy Research Programme funding stream (grant code: 019/0060). We thank the two 329 
anonymous reviewers for their thorough and helpful feedback on the manuscript. 330 
RUNNING HEAD: COMMUNICATING TO INCREASE PUBLIC UPTAKE OF FLU VACCINATION 
 
14 
 
Author contributions  331 
All authors contributed to the design of the study. The first and second authors sought and obtained 332 
ethical approval for the study, recruited and interviewed all the participants. The first and the last 333 
authors led the analysis of the data. All authors participated in the writing of the article, and all 334 
authors approved the final article.   335 
Conflict of interest 336 
All authors report no conflict of interest. 337 
References  338 
 339 
1. Smith RD, Keogh-Brown MR, Barnett T, Tait J. The economy-wide impact of pandemic 340 
influenza on the UK: a computable general equilibrium modelling experiment. British Medical 341 
Journal. 2009;339. 342 
2. Lohm D, Davis M, Flowers P, Stephenson N. 'Fuzzy' virus: indeterminate influenza biology, 343 
diagnosis and surveillance in the risk ontologies of the general public in time of pandemics. Health 344 
Risk & Society. 2015;17(2):115-31. 345 
3. Organization WH. Weekly epidemiological record: vaccines against influenza WHO    position 346 
paper – November 2012. 2012. 347 
4. Sethi M, & Peabody, R. . Pandemic H1N1 (swine) influenza vaccine uptake amongst patient 348 
groups in primary care in England 2009/10. In: Health UDo, editor. 2010a. 349 
5. Bish A, Yardley L, Nicoll A, Michie S. Factors associated with uptake of vaccination against 350 
pandemic influenza: A systematic review. Vaccine. 2011;29(38):6472-84. 351 
6. Sethi M, & Peabody, R. . Pandemic H1N1 (swine flu) and seasonal influenza vaccine uptake 352 
amongst frontline healthcare workers in England 2009/2010. In: Health UDo, editor. 2010b. 353 
7. Brien S, Kwong JC, Buckeridge DL. The determinants of 2009 pandemic A/H1N1 influenza 354 
vaccination: A systematic review. Vaccine. 2012;30(7):1255-64. 355 
8. Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND. Meta-analysis 356 
of the relationship between risk perception and health behavior: The example of vaccination. Health 357 
Psychology. 2007;26(2):136-45. 358 
9. Weinstein ND, Kwitel A, McCaul KD, Magnan RE, Gerrard M, Gibbons FX. Risk perceptions: 359 
Assessment and relationship to influenza vaccination. Health Psychology. 2007;26(2):146-51. 360 
10. Blank PR, Bonnelye G, Ducastel A, Szucs TD. Attitudes of the General Public and General 361 
Practitioners in Five Countries towards Pandemic and Seasonal Influenza Vaccines during Season 362 
2009/2010. Plos One. 2012;7(10). 363 
11. Boehmer MM, Walter D, Falkenhorst G, Mueters S, Krause G, Wichmann O. Barriers to 364 
pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic 365 
season in Germany. Bmc Public Health. 2012;12. 366 
12. Han YKJ, Michie S, Potts HWW, Rubin GJ. Predictors of influenza vaccine uptake during the 367 
2009/10 influenza A H1N1v ('swine flu') pandemic: Results from five national surveys in the United 368 
Kingdom. Preventive Medicine. 2016;84:57-61. 369 
RUNNING HEAD: COMMUNICATING TO INCREASE PUBLIC UPTAKE OF FLU VACCINATION 
 
15 
 
13. Rubin GJ, Potts HWW, Michie S. The impact of communications about swine flu (influenza A 370 
H1N1v) on public responses to the outbreak: results from 36 national telephone surveys in the UK. 371 
Health Technology Assessment. 2010;14(34):183-266. 372 
14. Rubinstein H, Marcu A, Yardley L, Michie S. Public preferences for vaccination and antiviral 373 
medicines under different pandemic flu outbreak scenarios. Bmc Public Health. 2015;15. 374 
15. Teasdale E, Yardley L. Understanding responses to government health recommendations: 375 
Public perceptions of government advice for managing the H1N1 (swine flu) influenza pandemic. 376 
Patient Education and Counseling. 2011;85(3):413-8. 377 
16. Teasdale E, Santer M, Geraghty AWA, Little P, Yardley L. Public perceptions of non-378 
pharmaceutical interventions for reducing transmission of respiratory infection: systematic review 379 
and synthesis of qualitative studies. Bmc Public Health. 2014;14. 380 
17. Siegrist M, Cvetkovich G. Perception of Hazards: The Role of Social Trust and Knowledge. 381 
Risk Analysis. 2000;20(5):713-20. 382 
18. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science. 383 
1981;211(4481):453-8. 384 
19. Detweiler JB, Bedell BT, Salovey P, Pronin E, Rothman AJ. Message framing and sunscreen 385 
use: Gain-framed messages motivate beach-goers. Health Psychology. 1999;18(2):189-96. 386 
20. Salovey P, Wegener, D.T. Communicating about Health: Message Framing, Persuasion, and 387 
Health Behavior. In: Wallston JSKA, editor. Social Psychological Foundations of Health and Illness. 388 
Malden, MA: Blackwell; 2003. 389 
21. Seale H, McLaws, M-L., Heywood, A.E., Ward, K.F., Lowbridge, C.P., Van, D., Gralton, J., & 390 
MacIntyre, C.R. . The community’s attitude towards swine flu and pandemic influenza. Medical 391 
Journal of Australia. 2009;191(5):267-9. 392 
22. Lynch MM, Mitchell EW, Williams JL, Brumbaugh K, Jones-Bell M, Pinkney DE, et al. Pregnant 393 
and Recently Pregnant Women’s Perceptions about Influenza A Pandemic (H1N1) 2009: Implications 394 
for Public Health and Provider Communication. Maternal and Child Health Journal. 2011;16(8):1657-395 
64. 396 
23. McNeill A, Harris P, Briggs P. Twitter influence on vaccination and antiviral uptake during the 397 
2009 H1N1 pandemic. Frontiers in Public Health. 2016;4. 398 
24. Ritov I, Baron J. Reluctance to vaccinate: Omission bias and ambiguity. Journal of Behavioral 399 
Decision Making. 1990;3(4):263-77. 400 
25. Brown KF, Kroll JS, Hudson MJ, Ramsay M, Green J, Vincent CA, et al. Omission bias and 401 
vaccine rejection by parents of healthy children: Implications for the influenza A/H1N1 vaccination 402 
programme. Vaccine. 2010;28(25):4181-5. 403 
26. Lagoe C, Farrar KM. Are you willing to risk it? The relationship between risk, regret, and 404 
vaccination intent. Psychology Health & Medicine. 2015;20(1):18-24. 405 
27. Joffe H, & Yardley, L. . Content and thematic analysis. In: Marks DF, & Yardley, L., editor. 406 
Research methods for clinical and health psychology. London Sage; 2004. 407 
28. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 408 
2006;3(2):77-101. 409 
29. Liberman A, Chaiken S. Defensive processing of personally relevant health messages 410 
Personality and Social Psychology Bulletin. 1992;18(6):669-79. 411 
30. van Koningsbruggen GM, Das E, Roskos-Ewoldsen DR. How Self-Affirmation Reduces 412 
Defensive Processing of Threatening Health Information: Evidence at the Implicit Level. Health 413 
Psychology. 2009;28(5):563-8. 414 
31. Godinho CA, Yardley, L., Marcu, A., Mowbray, F., Beard, E., & Michie, S. . Increasing the 415 
uptake of pandemic influenza vaccination: Testing the impact of theory-based messages. in press. 416 
32. Maheswaran D, Meyerslevy J. The influence of message framing and issue involvement 417 
Journal of Marketing Research. 1990;27(3):361-7. 418 
RUNNING HEAD: COMMUNICATING TO INCREASE PUBLIC UPTAKE OF FLU VACCINATION 
 
16 
 
33. Block LG, Keller PA. When to Accentuate the Negative: The Effects of Perceived Efficacy and 419 
Message Framing on Intentions to Perform a Health-Related Behavior. Journal of Marketing 420 
Research. 1995;32(2):192-203. 421 
34. O'Keefe DJ, Jensen JD. The Relative Persuasiveness of Gain-Framed and Loss-Framed 422 
Messages for Encouraging Disease Detection Behaviors: A Meta-Analytic Review. Journal of 423 
Communication. 2009;59(2):296-316. 424 
35. Cox D, Sturm L, Cox AD. Effectiveness of Asking Anticipated Regret in Increasing HPV 425 
Vaccination Intention in Mothers. Health Psychology. 2014;33(9):1074-83. 426 
36. Abraham C, Sheeran P. Deciding to exercise: The role of anticipated regret. British Journal of 427 
Health Psychology. 2004;9:269-78. 428 
37. Godin G, Sheeran P, Conner M, Delage G, Germain M, Belanger-Gravel A, et al. Which Survey 429 
Questions Change Behavior? Randomized Controlled Trial of Mere Measurement Interventions. 430 
Health Psychology. 2010;29(6):636-44. 431 
38. Milne S, Sheeran P, Orbell S. Prediction and intervention in health-related behavior: A meta-432 
analytic review of protection motivation theory. Journal of Applied Social Psychology. 433 
2000;30(1):106-43. 434 
39. Teasdale E, Yardley L, Schlotz W, Michie S. The importance of coping appraisal in behavioural 435 
responses to pandemic flu. British Journal of Health Psychology. 2012;17:44-59. 436 
40. Henrich N, Holmes B. The public's acceptance of novel vaccines during a pandemic: a focus 437 
group study and its application to influenza H1N1. Emerging health threats journal. 2009;2:e8-e. 438 
41. Rubin GJ, Finn Y, Potts HWW, Michie S. Who is sceptical about emerging public health 439 
threats? Results from 39 national surveys in the United Kingdom. Public Health. 2015;129(12):1553-440 
62. 441 
42. Yardley L, Morrison L, Bradbury K, Muller I. The person-based approach to intervention 442 
development: application to digital health-related behavior change interventions. Journal of medical 443 
Internet research. 2015;17(1):e30-e. 444 
43. Malterud K, Siersma VD, Guassora AD. Sample Size in Qualitative Interview Studies: Guided 445 
by Information Power. Qualitative Health Research. 2015. 446 
44. Bish A, Michie S. Demographic and attitudinal determinants of protective behaviours during 447 
a pandemic: A review. British Journal of Health Psychology. 2010;15:797-824. 448 
45. Endrich MM, Blank PR, Szucs TD. Influenza vaccination uptake and socioeconomic 449 
determinants in 11 European countries. Vaccine. 2009;27(30):4018-24. 450 
46. Webb TL, Sheeran P. Does changing behavioral intentions engender bahaviour change? A 451 
meta-analysis of the experimental evidence. Psychological Bulletin. 2006;132(2):249-68. 452 
 453 
  454 
RUNNING HEAD: COMMUNICATING TO INCREASE PUBLIC UPTAKE OF FLU VACCINATION 
 
17 
 
Figure 1. Pandemic influenza scenario text 455 
 456 
 HEALTH CONSEQUENCES: A new strain of flu virus is now spreading throughout the world and a 457 
pandemic flu outbreak has been declared. Most people who catch pandemic flu will feel very ill 458 
for many days, with high fever, severe chills, muscle pain and headache. Some people who catch 459 
pandemic flu will have no symptoms but will however transmit the infection to others around 460 
them and thus keep the virus in circulation. Around 1 in every 100 people who catch this flu 461 
become so ill that they need hospital care, and about 1 in every 1000 infected people die. 462 
 IMPACT: At this point, scientists do not yet know how badly the flu virus will affect people in the 463 
UK - doctors are trying to learn about the virus as fast as they can, but do not know if the pandemic 464 
will be mild or serious. When the virus spreads widely across the UK, we don’t know whether life 465 
will carry on much as usual or whether there will be serious problems with services such as the 466 
NHS, schools and vital supplies. Health care may need to be prioritised for the most seriously ill. 467 
Other essential services (e.g. postal service, refuse collection, fire & police services, public 468 
transport and shops) may be disrupted, too, if people are absent due to flu illness. 469 
 VACCINATION ADVICE: A new vaccine has been developed and pandemic flu vaccination is 470 
advised for all members of the general public, including children over six months of age. You will 471 
be invited to go to an immunisation clinic or to make an appointment at your surgery. If you don’t 472 
hear from your GP surgery, get in touch with them and arrange a vaccination appointment. 473 
 474 
 475 
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Table 1.  Messages seen by participants  477 
Vaccination Messages 
Risk-reducing Health-enhancing 
1a. By getting vaccinated against pandemic flu, 
you will prevent the infection from spreading to 
your family and work colleagues. 
1b. Getting vaccinated against pandemic flu will 
help you stay healthy, active, and able to look 
after your family during the current pandemic. 
2a. Have the pandemic flu jab today! It will 
prevent you from becoming infected and 
seriously ill with flu. 
2b. Getting vaccinated against pandemic flu will 
strengthen your body’s natural defences. 
3a. You should get vaccinated to protect 
yourself from getting pandemic flu. Vaccination 
will reduce your risk of infection.  
3b. You should get the pandemic flu 
vaccination. Vaccination will boost your natural 
immune system. 
4a. Getting vaccinated against pandemic flu 
reduces your chances of becoming infected and 
developing complications if you were to catch 
flu. 
4b. Have the pandemic flu jab today! It will help 
you maintain healthy levels of antibodies. 
Antiviral Messages 
Risk-reducing Health-enhancing 
5a. If you are in a priority group, taking antiviral 
medicines will reduce your risk of catching flu. 
5b. If you are prescribed antiviral medicines, 
you should take the full course to stay healthy, 
active, and able to look after your family. 
6a. Only by taking a full course of antiviral 
medicines like Tamiflu will you reduce your risk 
of becoming infected and seriously ill with flu. 
6b. If you are prescribed antiviral medicines by 
your GP, taking them will boost your body’s 
natural defences. 
7a. If you are in a priority group, taking antiviral 
medicines will prevent the infection from 
spreading to your family and work colleagues. 
7b. Only by taking a full course of antiviral 
medicines like Tamiflu will you maintain healthy 
levels of antibodies. 
8a. If you are prescribed antiviral medicines, 
you should take the full course to reduce your 
chances of becoming infected with pandemic 
flu. 
8b. If you are recommended antiviral medicines 
by your GP, taking them will boost your natural 
immune system. 
Emotion-focused, anticipated regret messages 
9. In this emergency situation it is essential to be vaccinated even though there may be a small 
risk of long-term side effects we don’t know about. 
10. You are more likely to feel upset if you got pandemic flu and had not been vaccinated, than 
feel upset if you got vaccinated. 
11. Nobody wants to do something they may regret, but the risk of harm from flu is much higher 
than the risk of side effects from vaccination. 
Fact-focused, A/H1N1 legacy messages 
12. In the last pandemic, a large number of children were affected by swine flu. 11 children died 
out of every 100,000 children infected. 
13. In the swine flu pandemic of 2009-2010, 70 children died. This is greater than the number of 
children who die from leukaemia each year. 
14. The children who did die from swine flu had not been vaccinated against swine flu. 
Vaccination would have saved their lives. 
15. About 1 million children were vaccinated against swine flu. While 11 experienced side effects, 
such as narcolepsy, none of them died. 
 478 
 479 
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Table 2. Demographic characteristics of the sample (n=41) 480 
Demographic characteristics 
Number / 
Proportion of the 
sample n (%) 
Gender   
Female 32 (78.0%) 
Male 9 (22.0%) 
Age   
16-24 years 12 (29.3%) 
25-34 years 12 (29.3%) 
35-44 years 8 (19.5%) 
45-54 years 3 (7.3%) 
55-75 years 6 (14.6%) 
Ethnicity   
White  28 (68.3%) 
Other  12 (29.3%) 
Prefer not to answer 1 (2.4%) 
Education   
Secondary education 8 (19.5%) 
Further education 3 (7.3%) 
College or university 30 (73.2%) 
Location  
Rural area or village 16 (39.0%) 
Large town or city 25 (61.0%) 
Children under 18 
Yes 
 
16 (39.0%) 
No 25 (61.0%) 
Perceive self to be at high risk of contracting flu   
Yes 14 (34.1%) 
Regularly vaccinate for seasonal flu since A/H1N1  
Yes  8 (19.5%) 
No 33 (80.5%) 
Was vaccinated during A/H1N1 pandemic  
      Yes 5 (12.2%) 
      No 33 (80.5%) 
      Can’t remember 3 (7.3%) 
Took antivirals during A/H1N1 pandemic  
      Yes 4 (9.8%) 
      No 32 (78.0%) 
      Can’t remember 5 (12.2%) 
 481 
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